Papers
2
Total Citations
37
H-Index
2
About
Honggang Qi is a pioneering urologic surgeon whose research centers on advancing minimally invasive surgical techniques, particularly through single-port robotic systems. His major contributions lie in evaluating the safety and efficacy of novel robotic platforms for complex urologic procedures. Qi’s work has been instrumental in demonstrating the clinical viability of the Shurui single-port robotic surgical system, with his most-cited papers reporting early outcomes in radical prostatectomy (20 citations) and partial nephrectomy (17 citations). These studies, published in 2023, provide critical evidence that single-port approaches can achieve favorable perioperative results while reducing surgical trauma. By prospectively enrolling patients with prostate cancer and T1a renal tumors, Qi has helped establish preliminary safety benchmarks that guide broader adoption of this technology. His research addresses a key challenge in urologic oncology—balancing oncologic control with functional preservation and recovery. For students and researchers, Qi’s work exemplifies how rigorous clinical evaluation of emerging surgical systems can translate innovation into practice, offering a roadmap for future studies on single-port robotics in urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2